Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret E Wierman

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
JAMA Internal Medicine|May 12, 2015
Risks of Different Testosterone Preparations: Too Much, Too Little, Just RightMargaret E Wierman
The Lancet. Oncology|April 12, 2024
Mitotane: a friend or a foe before cabozantinib treatment in adrenocortical cancer?Margaret E Wierman
Advances in Physiology Education|March 1, 2007
Sex steroid effects at target tissues: mechanisms of actionMargaret E Wierman
Clinical Obstetrics and Gynecology|September 24, 2021
Do Women Need Androgens Like a Fish Needs a Bicycle? A Review of the Literature and Clinical GuidelinesNanette Santoro, Margaret E Wierman
Reproductive Sciences (Thousand Oaks, Calif.)|July 24, 2007
Vascular and metabolic effects of sex steroids: new insights into clinical trialsMargaret E Wierman, Wendy M Kohrt
Clinical Endocrinology|April 28, 2011
How should postmenopausal androgen excess be evaluated?Micol S Rothman, Margaret E Wierman
The New England Journal of Medicine|July 21, 2017
Preventing Fat Gain by Blocking Follicle-Stimulating HormoneWendy M Kohrt, Margaret E Wierman
The Journal of Clinical Endocrinology and Metabolism|March 7, 2022
Should Dehydroepiandrosterone Be Administered to Women?Margaret E Wierman, Katja Kiseljak-Vassiliades
Pituitary|April 12, 2008
Female hypogonadism: evaluation of the hypothalamic-pituitary-ovarian axisMicol S Rothman, Margaret E Wierman
Transactions of the American Clinical and Climatological Association|August 13, 2024
ADRENOCORTICAL CARCINOMA: AN ORPHAN MALIGNANCY: FROM THE PATIENT TO THE BENCH AND BACKMargaret E Wierman, Katja Kiseljak Vassiliades
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
JAMA Internal Medicine|May 12, 2015
Risks of Different Testosterone Preparations: Too Much, Too Little, Just RightMargaret E Wierman
The Lancet. Oncology|April 12, 2024
Mitotane: a friend or a foe before cabozantinib treatment in adrenocortical cancer?Margaret E Wierman
Advances in Physiology Education|March 1, 2007
Sex steroid effects at target tissues: mechanisms of actionMargaret E Wierman
Clinical Obstetrics and Gynecology|September 24, 2021
Do Women Need Androgens Like a Fish Needs a Bicycle? A Review of the Literature and Clinical GuidelinesNanette Santoro, Margaret E Wierman
Reproductive Sciences (Thousand Oaks, Calif.)|July 24, 2007
Vascular and metabolic effects of sex steroids: new insights into clinical trialsMargaret E Wierman, Wendy M Kohrt
Clinical Endocrinology|April 28, 2011
How should postmenopausal androgen excess be evaluated?Micol S Rothman, Margaret E Wierman
The New England Journal of Medicine|July 21, 2017
Preventing Fat Gain by Blocking Follicle-Stimulating HormoneWendy M Kohrt, Margaret E Wierman
The Journal of Clinical Endocrinology and Metabolism|March 7, 2022
Should Dehydroepiandrosterone Be Administered to Women?Margaret E Wierman, Katja Kiseljak-Vassiliades
Pituitary|April 12, 2008
Female hypogonadism: evaluation of the hypothalamic-pituitary-ovarian axisMicol S Rothman, Margaret E Wierman
Transactions of the American Clinical and Climatological Association|August 13, 2024
ADRENOCORTICAL CARCINOMA: AN ORPHAN MALIGNANCY: FROM THE PATIENT TO THE BENCH AND BACKMargaret E Wierman, Katja Kiseljak Vassiliades
Pageof 12